Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 05, 2021
Sepha has launched a contract packaging service for small batch production.
read more
Friday, February 05, 2021
Moleculin Biotech has signed an agreement with Catalyst to manage its US clinical trial to study the ability of Annamycin to treat soft tissue sarcoma that has metastasized to the lungs.
read more
Monday, February 08, 2021
X-Chem has entered into a research collaboration and license agreement with Genentech.
read more
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Monday, February 08, 2021
Emmes announced progress in its role as Data Coordinating Center for studies conducted under the Best Pharmaceuticals for Children Act (BPCA).
read more
Monday, February 08, 2021
Noble has announced the launch of “Human Factors Plus” (HF+), an expanded service to further optimize the patient self-administration experience by supporting its customers.
read more
Monday, February 08, 2021
Immunome announced that Abzena was selected as Immunome’s partner research organization for IMM-BCP-01, an investigational therapeutic antibody cocktail for the treatment of COVID-19 being developed to target multiple SARS-CoV-2 antigens.
read more
Monday, February 08, 2021
Xylyx Bio and Cell&Soft announced positive preliminary results, reaching a key milestone in their partnership to develop more physiologically relevant in vitro cellular models for cell-based assays in oncology.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
Tuesday, February 09, 2021
Element has acquired a pharmaceutical analytical testing company, Avomeen, strengthening the Group’s Life Sciences business unit in North America.
read more
Tuesday, February 09, 2021
WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.
read more
Wednesday, February 10, 2021
Alphageneron has signed an Exclusive License Agreement with Multimmune for its clinical stage autologous NK cell therapy and companion diagnostic platform.
read more
Wednesday, February 10, 2021
FairJourney Biologics and IONTAS have announced the launch of a new protein sciences division, Flow Eighteen38.
read more
Wednesday, February 10, 2021
Catalent hadssigned an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
read more
Wednesday, February 10, 2021
Longevity Acquisition and 4D pharma have announced a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for BAVENCIO.
read more